Retrospective Study
Copyright ©The Author(s) 2020.
World J Clin Cases. May 26, 2020; 8(10): 1859-1870
Published online May 26, 2020. doi: 10.12998/wjcc.v8.i10.1859
Table 1 Gender distribution, clinical appearance and average stenosis rate in patients with carotid artery stenosis
Characteristicn%
GenderFemale1726.6
Male4773.4
Clinical appearanceAsymptomatic1218.8
Symptomatic5281.2
Average stenosis rateAsymptomatic-68.33
Symptomatic-74.69
Table 2 Accompanying comorbid diseases and risk factors for cases with carotid artery stenosis
Comorbid diseases and risk factorsn%
Hypertension3830.2
Diabetes mellitus2217.5
Cerebrovascular disease2015.9
Coronary artery disease1511.9
Hyperlipidemia97.1
Smoking86.3
Goiter54.0
Chronic obstructive pulmonary disease43.2
Congestive heart failure21.6
Asthma10.8
Glaucoma10.8
Familial mediterranean fever10.8
Table 3 Side and location of carotid artery stenosis and distribution of atherosclerotic plaque morphology
Parametersn%
Side of stenosisRight3351.6
Left3148.4
Location of stenosisCCA distal and ICA bulb69.3
ICA bulb4265.6
Dissection of ICA bulb11.6
Distal of ICA bulb46.3
ICA bulb origin34.6
Proximal of ICA bulb23.1
Post-bulbar ICA and bulb11.6
Petrous ICA11.6
Post-bulbar ICA46.3
Plaque morphologyShort segment regular surfaced46.3
Short segment irregular surfaced23.2
Short segment ulcerated23.2
Long segment regular surfaced1930.1
Long segment irregular surfaced1219.1
Long segment ulcerated2438.1
Table 4 Location and distribution by vascular territories of ischemic lesions which developed after carotid artery stenting based on diffusion-weighted imaging
Parametersn%
Location of cerebral parenchymal lesion
Occipital lobe1128.2
Frontal lobe1025.6
Parietal lobe820.5
Basal ganglions37.7
Cerebellum25.1
Frontoparietal12.6
Parietooccipital12.6
Frontoparietooccipital12.6
Occipitotemporoparietal12.6
Corpus callosum12.6
Cerebral vascular territory
MCA1538.5
PCA820.5
MCA-PCA “watershed”717.9
ACA37.7
ACA-MCA “watershed”25.1
ACA-MCA and MCA-PCA “watershed”25.1
PICA12.6
SCA12.6
Table 5 Technical properties, ischemic lesion numbers and complications in carotid artery stenting procedures
Case No.AgeGenderStenosis localizationBalloon angioplastyEmbolic protection deviceIpsilateral lesionContralateral lesionComplication
359ML ICA bulb++5-Silent ischemia
671ML ICA bulb++1-Silent ischemia
872ML ICA bulb++3-Silent ischemia
971FL ICA bulb++2-Silent ischemia
1178ML ICA bulb-+3-Silent ischemia
1372ML ICA distal to bulb++1-Symptomatic ischemia
1571MR ICA bulb++1-Silent ischemia
1662FL ICA bulb++43Silent ischemia
1775FR ICA bulb++-1Silent ischemia
1968ML post-bulbar ICA++2-Silent ischemia
2367MR ICA bulb++1-Silent ischemia
2684ML ICA bulb++-1Symptomatic ischemia
2976ML post-bulbar ICA++1-Symptomatic ischemia
3670FR ICA bulb++-1Silent ischemia
3876MR ICA bulb++1-Silent ischemia
4674ML ICA bulb++3-Silent ischemia
5268FR ICA bulb++1-Symptomatic ischemia
5472FR ICA bulb++2-Silent ischemia
5867MR ICA bulb++1-Silent ischemia
5967ML ICA bulb++1-Symptomatic ischemia
Table 6 Time to symptom development, neurological symptoms and prognosis in symptomatic patients after carotid artery stenting
Case No.Time to symptom developmentNeurological symptomsPrognosis
131st hourLoss of upper limb strength, right lower limb hemiparesisRight upper limb muscle strength 4/5
265th hourRestlessness, agitationRecovery without sequelae
2919th hourMotor aphasia, right upper limb muscle strength 2/5, plegia of right legRight upper limb muscle strength 4/5, dysdiadochokinesia
5222nd hourHemiparesisRecovery without sequelae
5924th hourCloudy vision, vertigo, ataxiaRecovery without sequelae